Aubrey de Grey: Methuselarity by 2035 – and it’ll be free

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

Aubrey de Grey tells Longevity.Technology the revolution is coming, and everyone will be eligible.

“I now think there is a 50% chance that we will reach longevity escape velocity by 2036. After that point (the “Methuselarity”), those who regularly receive the latest rejuvenation therapies will never suffer from age-related ill-health at any age.” So said eminent biomedical gerontologist and co-founder of the SENS Research Foundation, Dr Aubrey de Grey recently on Twitter.

Longevity.Technology: the idea of a Longevity Escape Velocity, or LEV, is one that is really gaining traction; it is the point where for every year we survive, we gain an extra year. As research continues to progress, life expectancy will continually be extended longer than the time that is passing. Is indefinite life extension on the cards and who does want to live forever?

Check out my fascinating quick-fire interview with Aubrey:

Aubrey de Grey on …

Mouse rejuvenation translated to humans:

We are considerably closer to robust mouse rejuvenation than we were 10 years ago … the gap between the achievement of robust mouse rejuvenation and the achievement of robust human rejuvenation is also, in my view, coming down quite fast.

Accuracy of the 2035 Methuselarity date:

When I make a prediction of any nature, about timeframes, I am aggregating all of the steps and looking at all of the potential bottlenecks, the potential delays, and evaluating what I feel they’re likely to be in terms of magnitude.

Longevity escape velocity – how young do you need to be to benefit?

Ovarian Longevity webinar

I think that actually the chance of somebody alive today benefiting from the Methuselarity and never getting sick as a result of how long ago they were born, that chance is much higher than 50%. It’s probably 80% or 90%. At this point, the chance of someone who is let’s say, 53, of reaching that is probably 40 or 50%.

Stem cell therapies and senolytics:

I absolutely think that stem cell therapies are going to be, literally, an essential pillar of the portfolio of damage repair approaches that we pursue … and indeed, at SENS Research Foundation, we have a study ongoing right now where we are combining stem cell treatment with senolytic drugs to kill senescent cells.

What’s the cost of LEV: is this just for rich people?

What’s it going to cost to the end-user: zero. And the reason is that aging is so expensive that it would be economically suicidal for any country not to make these things available, irrespective of ability to pay, to everybody who’s old enough to need them. And thereby to allow those therapies to pay for themselves many times over really quickly, just by keeping the elderly, able-bodied, and healthy, and in a position to contribute wealth.

Image credit: SENS Research Foundation

2 COMMENTS

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

The Sheekey Science Show – restoring brain health with bacteria

The Sheekey Science Show explains how the relationship between your gut and your brain can improve your lifespan and healthspan from top to toe. You...

Mike Murphy on mitochondria and keeping them healthy

The Co-Creator of MitoQ, Professor Mike Murphy, dives into the science behind mitochondrial health and the relationship with aging. Mike Murphy is Professor of Mitochondrial...

The Sheekey Science Show – VEGF

VEGF to extend lifespan? (targeting vascular aging) "A Man is as old as his arteries". This famous quote from English physician Thomas Sydenham depicts how...

The Sheekey Science Show – Aging Clocks

Aging clocks - how to measure biological age. I hope you have some time on you hands as today we will talk all about aging...

Sergey Young: breaking the barrier of maximum lifespan

Ahead of the launch of his new book Growing Young, Sergey Young joins us for a video interview to discuss longevity horizons, personal health...
Nutriop